“Introduction: The World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic on March 11, 2020. Two vaccine types were developed using two different technologies: viral vectors and mRNA. Thrombosis is one of the most severe and atypical adverse effects of vaccines. This study aimed to analyze published cases of thrombosis after COVID-19 vaccinations to identify patients’ features, potential pathophysiological mechanisms, timing of appearance of the adverse events, and other critical issues…
Discussion: Vaccine-induced thrombotic thrombocytopenia (VITT) is an unknown nosological phenomenon secondary to inoculation with the COVID-19 vaccine. Several hypotheses have been formulated regarding its physiopathological mechanism. Recent studies have assumed a mechanism that is assimilable to heparin-induced thrombocytopenia, with protagonist antibodies against the PF4–polyanion complex. Viral DNA has a negative charge and can bind to PF4, causing VITT. New experimental studies have assumed that thrombosis is related to a soluble adenoviral protein spike variant, originating from splicing events, which cause important endothelial inflammatory events, and binding to endothelial cells expressing ACE2.”
© 2023 Frontiers Media S.A. All rights reserved.
"Licences (Permissions) You Grant as an Author
When you submit an article (which includes the article abstract, but excludes article metadata, as defined below) to any Journal, you grant to Frontiers and/or to the Hosted Journal owner and to the world at large a permanent, non-cancellable, free-of-charge, worldwide licence (permission) to publish, display, store, copy, adapt and re-use that article – including any third-party materials – and to create derivative works from it."
Source: https://www.frontiersin.org/legal/terms-and-conditions